Dobutamine-Induced Strain and Strain Rate Predict Viability Following Fibrinolytic Therapy in Patients with ST-Elevation Myocardial Infarction by Mohamed Ismail & Wail Nammas
ORIGINAL RESEARCH IN MEDICINE
published: 11 March 2015
doi: 10.3389/fcvm.2015.00012
Edited by:
Oscar Horacio Cingolani,
Johns Hopkins University, USA
Reviewed by:
Thorsten Leucker,
Johns Hopkins University, USA
Ismail Dogu Kilic,
Pamukkale University, Turkey
*Correspondence:
Wail Nammas,
Cardiology Department, Faculty of
Medicine, Ain Shams University,
Abbassia, P.O. 11381, Cairo, Egypt
wnammas@hotmail.com
Specialty section:
This article was submitted to General
Cardiology, a section of the journal
Frontiers in Cardiovascular Medicine
Received: 13 January 2015
Accepted: 25 February 2015
Published: 11 March 2015
Citation:
Ismail M and Nammas W (2015)
Dobutamine-induced strain and strain
rate predict viability following
fibrinolytic therapy in patients with
ST-elevation myocardial infarction.
Front. Cardiovasc. Med. 2:12.
doi: 10.3389/fcvm.2015.00012
Dobutamine-induced strain and
strain rate predict viability following
fibrinolytic therapy in patients with
ST-elevation myocardial infarction
Mohamed Ismail and Wail Nammas *
Cardiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Background: Low-dose dobutamine stress echocardiography is increasingly used for
identifying myocardial viability.
Aim: We explored whether dobutamine-induced strain (S) and strain rate (SR) can
identify myocardial viability following fibrinolytic therapy for ST-segment-elevation myocar-
dial infarction (STEMI), taking 99mTc-sestamibi scintigraphy as the “gold standard” for
diagnosis.
Methods: We enrolled 60 consecutive patients presenting for myocardial viability
assessment at least 4weeks following STEMI. S and SR were measured by tissue
Doppler imaging individually for all myocardial segments under low-dose dobutamine
stress echocardiography. Patients underwent resting 99mTc-sestamibi scintigraphy using
the standard imaging technique. Based on the results of 99mTc-sestamibi scintig-
raphy, the dobutamine-induced S and SR were compared between viable and
non-viable segments. Receiver-operating characteristics curve was constructed to
determine the cutoff value of the dobutamine-induced S and SR that best identifies
viability.
Results: The dobutamine-induced S and SR were significantly higher in viable
compared with non-viable segments, a finding that was consistent for most individual
myocardial segments (10 out of 16 for S and 11 out of 16 for SR). A cutoff value ranging
from  8.5 to  9.6% for the S identified viability in apical and mid- segments, whereas a
cutoff value ranging from 11.5 to 21.5% identified viability in basal segments. Similarly,
a cutoff value ranging from  0.5 to  1.2 s 1 for the SR identified viability in apical and
mid-segments, whereas a cutoff value ranging from  1.4 to  1.7/s 1 identified viability
in basal segments.
Conclusion: In patients undergoing viability assessment following fibrinolytic therapy
for STEMI, the dobutamine-induced S and SR were higher in viable versus non-viable
segments. A cutoff value of dobutamine-induced S and SR identified viability in most
individual myocardial segments.
Keywords: strain rate imaging, myocardial deformation indices, dobutamine stress echocardiography, myocardial
infarction, viability
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Introduction
Identification of viable myocardium following acute myocardial
infarction has gained crucial importance with the recent step-
up in myocardial revascularization techniques. The amount of
viable myocardium is a “surrogate” of future improvement of
left ventricular systolic function: the most powerful single pre-
dictor of long-term prognosis (1). Traditionally, evaluation of
regional myocardial function was performed by visual assessment
of thickening and inward displacement of individual myocardial
segments. Limited by operator dependency and poor visualization
of some myocardial segments, it was largely supplanted by esti-
mation of tissue velocities, using tissue Doppler imaging (TDI).
However, this technique is influenced by whole heart translation
and tethering movement from adjacent myocardial segments (2).
Eventually, assessment of myocardial deformation indices cir-
cumvented these limitations. Evidence supports the superiority of
strain (S) and strain rate (SR) measurement over tissue velocity by
TDI for the evaluation of regional myocardial function (3–5).
Low-dose dobutamine stress echocardiography (DSE) is well-
acknowledged for identifying viable myocardium. Dobutamine-
induced wall motion improvement is specific for predicting
reversible contractile dysfunction; however, its sensitivity is sub-
optimal (6). Yet, the value of dobutamine-induced myocardial
deformation indices (S and SR) for detection of myocardial viabil-
ity remains unclear. Therefore, we explored whether dobutamine-
induced S and SR can identify myocardial viability following
fibrinolytic therapy for ST-segment-elevation myocardial infarc-
tion, taking 99mTc-sestamibi scintigraphy as the “gold standard”
for diagnosis.
Materials and Methods
Patient Selection and Study Design
Prospectively, we enrolled 60 consecutive patients who pre-
sented to our nuclear cardiology unit for myocardial viabil-
ity assessment, at least 4 weeks following ST-segment-elevation
myocardial infarction, during the period from May 2012 to May
2013. All patients had received fibrinolytic therapy (streptokinase
1,500,000U, given by intravenous infusion over 30–60min), that
started within 12 h of the onset of chest pain. Patients were con-
sidered eligible for inclusion if they had regional wall motion
abnormality in the anatomical distribution of the infarct zone as
detected by resting 2-D echocardiography. We excluded patients
with early post-infarction unstable angina or severe hemodynamic
instability, clinically evident congestive heart failure, significant
valvular or congenital heart disease, any myocardial disease apart
from ischemia, atrial fibrillation, bundle branch block, and techni-
cally inadequate echocardiographic imaging defined as more than
two non-analyzable segments in the infarct zone. Similarly, we
excluded from analysis segments with poor stain or strain rate sig-
nal (due to low signal-to-noise ratio or reaching aliasing velocity).
Before inclusion, informed written consent was obtained from
each patient after full explanation of the study protocol. Finally,
the study protocol was reviewed and approved by the institu-
tional Human Research Committee, as it conforms to the ethical
guidelines of the 1964 Declaration of Helsinki, as revised in 2013.
Baseline Echocardiographic Assessment
Assessment of regional and global left ventricular systolic function
was performed by trans-thoracic echocardiography, using a Gen-
eral Electric Vivid 7 Pro cardiac ultrasound machine (GEMedical
Systems,Horten,Norway) equippedwith harmonic imaging capa-
bilities. A 3.5MHz phased-array transducer was used to obtain
standard 2-D, M-mode, Doppler flow, and TDI. Patients were
examined in the left lateral recumbent position using standard
parasternal and apical views. Global left ventricular systolic func-
tion was assessed in apical 2- and 4-chamber views using the
biplane Simpson’s method. Regional wall motion was assessed
according to the standard 16-segmentmodel recommended by the
American Society of Echocardiography (7).
Strain and Strain Rate Imaging
Strain color imaging was performed one wall at a time in order
to achieve a frame rate above 140 frames/s, and so that the
angle between the Doppler beam and the longitudinal shortening
direction of the wall was kept below 30°. Systolic S and SR mea-
surement were performed for all analyzable segments according
to the standard 16-segment model. An offset to measure S and
SR was set at 12mm. The stationary region of interest was 10mm
in longitude, and 6mm in latitude, centered in the middle of the
targeted myocardial segment. Systolic time to measure systolic
S and SR was determined from the electrocardiographic tracing
as the time from the peak of the R wave to the end of the T
wave. Peak systolic S was determined as the maximal negative
S at the end of systole. Peak systolic SR was determined as the
maximal negative SR within 350ms after the onset of systole.
Measurements were obtained from three cardiac cycles and an
average was taken. Cardiac cycles associated with extra-systolic,
post-extra-systolic beats, or any other rhythm disturbances were
excluded from analysis.
Stress Echocardiographic Protocol
All patients underwent low-dose DSE as follows: dobutamine
(Dobutrex®, Lilly, Eli and Company, Indianapolis, IN. USA) was
infused intravenously starting at 5 µg/kg/min, increased up to
20 µg/kg/min in 3-min stages. Standard views were recorded at
baseline, as well as at the end of the infusion protocol. Images
were digitized in cine-loop format and saved for subsequent
playback and analysis. Views were analyzed offline by a single
observer (Mohamed Ismail) employing the software program of
the echocardiography machine (Echopac PC, GE Vingmed Ultra-
sound, GE Medical Systems). Systolic S and SR measurements
were performed individually for each segment, both at baseline
and at the end of dobutamine infusion (Figures 1 and 2). The
stress test was performed with the patients on their full anti-
ischemic medications.
99mTc-sestamibi Scintigraphy Imaging Protocol
Patients underwent resting 99mTc-sestamibi imaging study with
the administration of trimetazidine, using the standard imaging
technique. Trimetazidine (Vastarel®, Servier, France) was admin-
istered by the oral route the day before the study (60mg in three
divided equal doses 8 h apart), and 1 h before performing the
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FIGURE 1 | Strain measurement with placement of sample on the
mid-anterior wall segment (A), strain at rest (heart rate 66beats/min)
(B) then with dobutamine (heart rate 110beats/min) (C).
FIGURE 2 | Strain rate measurement with placement of sample on the
mid-anterior wall segment (A), strain rate at rest (heart rate 66beats/
min) (B) then with dobutamine (heart rate 112beats/min) (C).
study (60mg single dose). Sublingual nitroglycerin 0.8mg was
administered in two divided doses with a 5-min interval just
before radioactive tracer administration. The second dose was
not given if the heart rate increased by 10 beats/min or more, or
the systolic blood pressure decreased by 10mm Hg or more after
the first dose. Injection of 20–25mCi of radioactive tracer was
performed 45–60min before SPECT image acquisition. Images
were acquired using a rotating single-head gamma camera (GE
Medical Systems, Starcam 4000i, UK) equipped with low-energy
all-purpose collimators. Energywindows of 20%were respectively
centered on the 140-keV peaks of 99mTc-sestamibi. Thirty-two
images were obtained over 180° extending from the 45° right
anterior oblique to the 45° left posterior oblique projections,
using a 64 64 acquisition matrix. All studies were subjected to
quality-control checks and corrections when necessary for camera
non-uniformity, center-of-rotation offsets, patient motion, and
“upward creep.”
99mTc-sestamibi Scintigraphy Image Analysis
Two experienced nuclear cardiologists blinded for both clini-
cal and TDI data analyzed the scintigraphy images. Trans-axial
reconstruction was performed using the standard back projection
technique with a Ramp-Hanning filter. The reconstructed tomo-
graphic slices were 6mm thick and reoriented along the short,
horizontal long-, and vertical long-axis for interpretation. The
vascular assignment of myocardial segments to the conventional
anatomic distribution of major coronary arteries was performed
according to the 17-segment Scoring System (8). Images were
interpreted by visual semi-quantitative analysis. Segmental 99mTc-
sestamibi uptake was scored using the 5-point Scoring System as
follows:
 0= normal uptake,
 1=mildly reduced uptake,
 2=moderately reduced uptake,
 3= severely reduced uptake,
 4= absent uptake.
Patterns of viability were based on the segmental radioactive
tracer uptake so that segments were then individually classified
into viable or non-viable. Score of 0 was considered as normal; 1
and 2 as viable; 3 and 4 as non-viable.
Statistical Analysis
Continuous variables were presented as mean SD, if they were
normally distributed. Data were tested for normal distribution
using the Kolmogorov–Smirnov test. Categorical variables were
described with absolute and relative (%) frequencies. According
to the above assignment of myocardial segments, dobutamine-
induced S and SR values were compared between viable and
non-viable groups in each individual anatomical segment by
means of the unpaired t-test. Eventually, we generated receiver-
operating characteristics curve to identify the cutoff value of
the dobutamine-induced S and SR that best discriminates viable
from non-viable myocardial segments based on 99mTc-sestamibi
scintigraphy. The optimal cutoff value was defined as the value
giving the largest area under the curve. Finally, ten cases were
randomly selected for analysis of intra-observer variability of
repeated measurement by the single observer. Assessment of
variability was performed using linear regression. All analy-
ses were two-sided and a probability value of p< 0.05 was
considered statistically significant. Analyses were performed
with SPSS version 12.0 statistical package (SPSS Inc., Chicago,
IL, USA).
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Results
A total of 60 consecutive patients presenting at least 4 weeks fol-
lowing ST-segment-elevationmyocardial infarction were enrolled
in the current study. Baseline characteristics of the study cohort
are presented inTable 1. Themean age was 54.8 10.9 years; 85%
weremales. Analysis of TDI-measured S and SRwas feasible in 954
segments (99.4%) of all 960 segments. These included 397 (41.4%)
segments defined as dyssynergic, and 557 (58%) defined as normal
by resting 2-D echocardiography. Among 397 (41.4%) defined
as dyssynergic at rest, 209 (21.8%) were assigned as severely
hypokinetic, 188 (19.6%) as akinetic or dyskinetic. Six segments
(0.6%) were considered as not feasible for S and SR measurement,
and thus were excluded from analysis. This was due to either low
signal-to-noise ratio, or aliasing in the velocity dataset that was not
perceived during image acquisition. 99mTc-sestamibi scintigraphy
image analysis was feasible in all segments.
Dobutamine-induced S was significantly higher in viable,
compared with non-viable segments in the following individual
myocardial segments:mid- and apical lateral, basal and apical pos-
teroseptal, mid- and apical anterior, basal and mid-anteroseptal,
basal and mid-posterior (p< 0.05 for all) (Table 2). Similarly,
dobutamine-induced SR was significantly higher in viable, com-
pared with non-viable segments in the following individual
myocardial segments:mid- and apical lateral, basal and apical pos-
teroseptal, mid- and apical anterior, apical inferior, basal andmid-
anteroseptal, basal and mid-posterior (p< 0.05 for all) (Table 3).
Receiver-operating characteristics curve analysis identified the
optimal cutoff value of the dobutamine-induced S and SR that
best discriminates viability – from non-viability – in the above
mentioned segments. Taking 99mTc-sestamibi scintigraphy as the
“gold standard” for diagnosis, a cutoff value ranging from –8.5 to
–9.6% for the S identified viability in apical and mid- segments,
whereas a cutoff value ranging from –11.5 to –21.5% identified
viability in basal segments (Table 4). Similarly, a cutoff value
ranging from –0.5 to –1.2/s 1 for the SR identified viability in
apical and mid- segments, whereas a cutoff value ranging from
–1.4 to –1.7/s 1 identified viability in basal segments (Table 5).
The DSE protocol was well-tolerated by all patients with
no major side effects during or after the test. The intra-class
TABLE 1 | Baseline clinical characteristics of the cohort.
Total cohort (N=60)
Age (years) 54.810.9
Male: gender 51 (85)
Diabetes mellitus 26 (43.3)
Hypertension 29 (48.3)
Smoking 43 (71.7)
Dislipidemia 13 (21.7)
Family history of IHD 18 (30)
2-D Ejection fraction (%) 358
Left ventricular EDD (mm) 627
Left ventricular ESD (mm) 495
Left atrial dimension (mm) 467
Continuous variables are presented as meanSD, whereas categorical variables are
presented as numbers (%).
IHD, ischemic heart disease; EDD, end-diastolic dimension; ESD, end-systolic dimension.
correlationbetween repeatedmeasurements by the single observer
(M.I.) was r= 0.91 (95% confidence interval 0.86–0.95) for the S,
and r= 0.93 (95% confidence interval 0.88–0.98) for the SR.
TABLE 2 | Dobutamine-induced strain values in individual myocardial seg-
ments.
Segment Viable Non-viable p Value
Basal lateral  15.95.2 NA NA
Mid-lateral  13.94.9  7.43.2 0.00
Apical lateral  11.44.8  7.73.7 0.00
Basal posteroseptal  25.810.4  13.66.8 0.00
Mid-posteroseptal  13.34.5  12.74.2 0.86
Apical posteroseptal  14.44.5  4.77.2 0.00
Basal anterior  21.18.0 NA NA
Mid-anterior  14.06.2  5.72.5 0.00
Apical anterior  13.58.4  5.62.1 0.00
Basal inferior  19.47.8  17.95.9 0.63
Mid-inferior  9.27.1  7.16.2 0.12
Apical inferior  8.96.7  5.64.7 0.26
Basal anteroseptal  2112.8  7.84.8 0.00
Mid-anteroseptal  12.05.4  8.56.1 0.04
Basal posterior  14.66.8  8.03.3 0.00
Mid-posterior  11.77.2  7.43.6 0.01
All values are expressed as %.
TABLE 3 | Dobutamine-induced strain rate values in individual myocardial
segments.
Segment Viable Non-viable p Value
Basal lateral  1.70.9 NA NA
Mid-lateral  1.30.1  0.370.7 0.00
Apical lateral  1.30.6  0.50.3 0.00
Basal posteroseptal  2.11.4  1.10.8 0.04
Mid-posteroseptal  1.80.6  1.40.9 0.09
Apical posteroseptal  1.40.6  0.60.5 0.00
Basal anterior  2.00.9 NA NA
Mid-anterior  1.30.4  0.40.5 0.00
Apical anterior  1.81.2  0.50.3 0.00
Basal inferior  1.30.4  1.20.5 0.14
Mid-inferior  0.80.7  0.90.5 0.23
Apical inferior  1.40.1  0.40.3 0.00
Basal anteroseptal  2.00.8  0.90.2 0.00
Mid-anteroseptal  1.30.6  0.90.2 0.04
Basal posterior  1.50.9  0.90.4 0.04
Mid-posterior  1.80.7  0.80.4 0.00
All values are expressed as s 1.
TABLE 4 | Cutoff values for dobutamine-induced strain that predict viability
in individual myocardial segments.
Segment Cutoff value Sensitivity (%) Specificity (%)
Mid-lateral  8.7 83.3 86.2
Apical lateral  8.5 63.6 85.7
Basal posteroseptal  21.5 100 61.3
Apical posteroseptal  8.8 81.2 89.3
Mid-anterior  9.7 100 82.7
Apical anterior  8.5 86.7 66.7
Basal anteroseptal  11.5 88.9 94.9
Mid anteroseptal  9.8 87.3 77.6
Basal posterior  10.9 84.2 79.6
Mid-posterior  9.2 68 72.4
All values are expressed as %.
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TABLE 5 | Cutoff values for dobutamine-induced strain rate that predict
viability in individual myocardial segments.
Segment Cutoff value (%) Sensitivity (%) Specificity (%)
Mid-lateral  0.5 83.3 100
Apical lateral  0.8 79.5 78.6
Basal posteroseptal  1.4 77.8 67.7
Apical posteroseptal  0.8 68.8 85.7
Mid-anterior  0.6 75 90.4
Apical anterior  0.9 91.1 80
Apical inferior  1.1 93.9 72.7
Basal anteroseptal  1.5 100 74.4
Mid-anteroseptal  1.1 94.1 43.9
Basal posterior  1.4 100 43.8
Mid-posterior  1.1 84 89.7
All values are expressed as s 1.
Discussion
Main Findings
The current study demonstrated that in patients undergoing via-
bility assessment following fibrinolytic therapy for ST-segment-
elevation myocardial infarction, the dobutamine-induced S and
SR were significantly higher in viable segments, compared with
non-viable ones, a finding that was consistent for most individual
myocardial segments (10 out of 16 for S and 11 out of 16 for SR).
Deformation Indices for Detection of Viability
DSE is known to be operator-dependent; and therefore, liable
for high inter- and intra-observer variability. Nevertheless, being
feasible, safe, and inexpensive, with a fairly high diagnostic and
prognostic accuracy, low-dose DSE is widely acknowledged for
evaluation of viability following myocardial infarction. In the
quest to overcome the subjective visual assessment of regional
contractility, a good body of research has rigorously pursued
to adopt quantitative measures of regional myocardial function
during low-dose DSE. Although appealing at the outset, TDI-
derived systolic tissue velocity was reportedly overwhelmed by
“tethering” effect from neighboring segments, as well as by whole
heart translation movement (2). Recently, some studies have
explored the potential of myocardial deformation indices for
the evaluation of myocardial viability (9–12). A recent report
demonstrated an incremental value of TDI-based S and SR during
low-dose DSE over wall motion analysis in the prediction of func-
tional recovery following revascularization (13). In another study,
longitudinal S and SR derived from speckle-tracking echocar-
diography under DSE demonstrated a similar sensitivity and a
higher specificity for detection of viability following myocardial
infarction, compared with SPECT (14). However, neither of these
latter studies addressed the issue of identifying a cutoff value for
the dobutamine-induced S and SR that best predicts viability in
individual myocardial segments.
Going a step further, we explored the theme of “which level”
of dobutamine-induced S and SR would identify viability in
individual myocardial segments. In this sense – and to the best
of the authors’ knowledge – the current study was the first to
identify cutoff values of the dobutamine-induced S and SR that
best recognize the viable segments on individual segment basis.
Moreover, our results serve to support the results obtained by
the prior studies, adding more strength to the “level of evidence.”
Unfortunately, however, the results were somewhat inconsistent;
favorable formany segments, but disappointing for some. The lack
of consistency of the results in both S and SRmight be attributed to
angle dependency, a well-known downside of the strain imaging
technique. Failure to keep the angle between the Doppler beam
and the longitudinal shortening direction of the segment below
30° may have precluded accurate measurement of S and SR in
some segments.
We adopted measurement of TDI-based S and SR for assess-
ment of myocardial viability by low-dose DSE. TDI-based mea-
sures have been constrained by susceptibility to signal noise
and dependence on the angle of insonation (2). The recently
introduced speckle-tracking echocardiography has no angle
dependency, but it needs adequate image quality and operates at
a limited frame rate (15, 16). Nevertheless, in a recent report by
Bansal et al., comparing the twomodalities for predictingmyocar-
dial viability under low-dose DSE, TDI-based measures were
more accurate, and predicted viability in both the anterior and
posterior circulation; whereas speckle-tracking echocardiography
measures predicted viability only in the anterior circulation (13).
99mTc-sestamibi Scintigraphy for Detection of
Viability
Since we adopted 99mTc-sestamibi scintigraphy as the “gold stan-
dard” for diagnosis of viability, we sought to improve its diag-
nostic accuracy. Thus, we employed a test protocol that entails
the administration of both trimetazidine and nitroglycerin before
radiotracer injection. A recent study by Feola et al. showed that
the addition of trimetazidine to 99mTc-tetrofosmin scintigraphy
improved the sensitivity of the perfusion scan for the detection
of viable myocardial tissue, both at 2- and 6-months follow-up,
comparedwith placebo,maintaining a satisfactory specificity (17).
Furthermore, the predictive power of 99mTc-sestamibi scintigra-
phy was also enhanced with the addition of nitrates, obtaining an
improvement in both the sensitivity and specificity (up to 95 and
88%, respectively) (18).
Clinical Implications
In many centers, low-dose DSE remains the mainstay for detec-
tion of myocardial viability. Identification of viability following
myocardial infarction is of paramount importance for the decision
to triage patients for revascularization procedures. Nevertheless,
the problems of needed expertise and lack of reproducibility have
always put low-dose DSE under intense scrutiny. In a trial to
improve the credibility of the widely popular test for viability
detection, an “objective” way of assessment is eagerly needed.
In this context, measurement of myocardial deformation indices
during low-dose DSE would offer a substantial upgrading for
the test. Moreover, the identification of cutoff values for the
dobutamine-induced S and SR for the individual myocardial seg-
ments would further present a palatable easy-to-perform way to
discriminate myocardial segments whose function will “recover”
following revascularization. Going this way, low-dose DSE would
potentially become the “standard of care” for viability detection in
a not-too-distant future.
Frontiers in Cardiovascular Medicine | www.frontiersin.org March 2015 | Volume 2 | Article 125
Ismail and Nammas Strain rate imaging with dobutamine echocardiography
Limitations of the Study
Our findings were based on a single center study with a relatively
small sample size of the cohort, a fact that makes it difficult to
generalize our results to all patients undergoing viability assess-
ment. Multicenter studies using the same protocol and examining
a larger number of patients are needed. Additionally, the current
technology of SR imaging is characterized by considerable noise in
the SR signal. This noise increases further with higher heart rates
and reduces image quality. Another limitation of the technique is
the angle-dependency, which makes determination of S and SR in
some segments less accurate. The adoption of a frame rate above
140 frames/s is another limitation. Furthermore, ECG tracking
was used to detect systolic time rather than aortic valve opening
and closure which is more accurate. Another limitation is that all
patients received fibrinolytic therapy, and none of the patients was
treated by primary percutaneous coronary intervention. It would
be of interest to see if primary percutaneous coronary intervention
shows greater viability in myocardial segments compared with
fibrinolysis. Finally, we adopted 99mTc-sestamibi scintigraphy as
the “gold standard” for diagnosis of viability. Actual improvement
of myocardial segment contractility following revascularization
would offer a more “real” gold standard for comparison.
Conclusion
In patients undergoing viability assessment following fibrinolytic
therapy for ST-segment-elevation myocardial infarction, the
dobutamine-induced S and SR were higher in viable compared
with non-viable segments. A cutoff value of dobutamine-induced
S and SR identified viability in most individual myocardial
segments.
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